share_log

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune治療公司股價上漲,此前該公司公佈了好於預期的第二季度每股收益業績,並重申了指導意見。
Benzinga ·  2022/08/04 14:56

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune治療公司股價上漲,此前該公司公佈了好於預期的第二季度每股收益業績,並重申了指導意見。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論